advanced abstracting issues for the lung cancer diagnosis
Download
Skip this Video
Download Presentation
Advanced Abstracting Issues for the Lung Cancer Diagnosis

Loading in 2 Seconds...

play fullscreen
1 / 36

Advanced Abstracting Issues for the Lung Cancer Diagnosis - PowerPoint PPT Presentation


  • 411 Views
  • Uploaded on

Advanced Abstracting Issues for the Lung Cancer Diagnosis. Judy Andrews, CTR Metropolitan Regional Coordinator Georgia Center for Cancer Statistics GATRA Fall Meeting 2004. ICD‑O-3 CODES . ICD‑0‑3 TERM C34.0 Main bronchus C34.1 Upper lobe, lung C34.2 Middle lobe, lung

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Advanced Abstracting Issues for the Lung Cancer Diagnosis' - daniel_millan


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
advanced abstracting issues for the lung cancer diagnosis

Advanced Abstracting Issues for the Lung Cancer Diagnosis

Judy Andrews, CTR

Metropolitan Regional Coordinator

Georgia Center for Cancer Statistics

GATRA Fall Meeting 2004

icd o 3 codes
ICD‑O-3 CODES
  • ICD‑0‑3 TERM

C34.0 Mainbronchus

C34.1 Upper lobe, lung

C34.2 Middle lobe, lung

C34.3 Lower lobe, lung

C34.8 Overlapping lesion of lung

C34.9 Lung, NOS

anatomy
Anatomy
  • Related adjectives: Lung= pneumo-, pulmono-, broncho-, bronchiolo-, alveolar, hilar
  • Breathing= -pnea (difficulty with breathing=dyspnea)
  • Paired organ
  • Subsites:
    • Right lobe: 3 lobes
    • Left Lobe: 2 lobes
lung anatomy
Lung Anatomy

Carina

Upper Lobe

Oblique

Fissure

Middle

Lobe

Lower

Lobe

lung anatomy key words
Lung Anatomy: Key Words
  • Apex
  • Hilum
  • Carina
  • Lingula
  • Cardiac Notch
  • Pleural Cavity
  • Chest Wall
  • Mediastinum
  • Base
icd o 3 morphology codes
ICD-O-3 Morphology Codes
  • Small cell lung cancers include ICD‑O-3 morphology codes M‑80413, M‑80423, M‑80433, M‑80443, and M80453
  • Common non‑small cell lung cancer histologies
      • Squamous or epidermoid (807_3)
      • Adenocarcinoma (814_3)
      • Bronchioloalveolar (82503)
      • Large cell carcinoma (80123)
      • Other subtypes of adenocarcinoma are acinar, papillary,and mucinous
      • Adenosquamous carcinoma (85603)
      • Mesothelioma (905_3)
      • Bronchogenic carcinoma IS NOT a specific cell type
regional lymph nodes for the lung
Regional Lymph Nodes for the Lung
  • The regional lymph nodes for the lung are all above the diaphragm
      • Intrathoracic nodes include mediastinal and intrapulmonary nodes
      • Scalene and supraclavicular nodes are also considered regional nodes for staging
regional lymph nodes for the lung8
Intrathoracic

Pulmonary

12 Peribronchial

11 Intrapulmonary

10 Hilar

13 Segmental

Superior mediastinal

1 Superior Mediastinal

3 Pretracheal,retrotracheal

2 Paratracheal

4 Lower paratracheal, azygos

Intrathoracic

Aortic

5 Subaortic (aortic window)

6 Para-aortic (ascending aorta or phrenic)

Inferior mediastinal

7 Carinal, subcarinal

8 Paraesophageal

9 Pulmonary ligament

Regional Lymph Nodes for the Lung
regional lymph nodes for the lung9
Regional Lymph Nodes for the Lung
  • Extrathoracic
    • Scalene
    • Supraclavicular or transverse cervical
common metastatic sites for the lung
Common Metastatic Sites for the Lung
  • Lymphatic Spread
      • Cervical Lymph Nodes
      • Contralateral Lung
      • Contralateral Mediastinum
  • Hematogenic Spread
      • Brain
      • Bone
      • Liver
      • Adrenal glands
      • Contralateral Lung
extent of disease evaluation for the lung
Extent of Disease Evaluation for the Lung
  • Diagnostic Studies: Physical Exam
      • Signs and Symptoms
      • Palpable lymph nodes or organs
      • Pancoast Tumor
      • Horner’s Syndrome
extent of disease evaluation for the lung12
Extent of Disease Evaluation for the Lung
  • Diagnostic Studies: Imaging
      • Chest X-ray
      • CAT Scan
      • MRI Scan
      • PET Scan
      • Bone Scan
extent of disease evaluation for the lung13
Extent of Disease Evaluation for the Lung
  • Diagnostic Studies: Endoscopies
      • Bronchoscopy
      • Mediastinoscopy
      • Thoracoscopy
extent of disease evaluation for the lung14
Extent of Disease Evaluation for the Lung
  • Diagnostic Studies: Pathological
      • Closed Chest Needle Biopsy
      • Cytology (Thoracentesis)
      • Sputum Cytology
      • Bronchial Washings
      • Bone Marrow Biopsy
extent of disease evaluation for the lung15
Extent of Disease Evaluation for the Lung
  • Diagnostic Studies: Tumor Markers
      • Neuron Specific Enolase (NSE)
      • Squamous Cell Carcinoma Antigen
      • DNA Studies
      • Adrenocorticotropic Hormone (ACTH)
      • Carcinoembryonic Antigen (CEA)
      • Calcitonin
      • Tissue Polypeptide Antigen (TPA)
staging systems for lung
Staging Systems for Lung
  • SEER Extent of Disease 3rd Edition

(Diagnosis year 1988-2003)

  • SEER Summary Staging 2000

(Diagnosis year 2001-2003)

  • American Joint Committee on Cancer (AJCC)

TNM 6th Edition

(Diagnosis year 2003 forward)

  • Collaborative Staging

(Diagnosis year 2004 forward)

staging systems for lung17
Staging Systems for Lung

SEER EOD

  • Size
  • Extent
  • Regional Lymph Nodes
  • Reg LN Positive
  • Reg LN Examined

SEER Summary Stage 2000

  • In Situ
  • Localized
  • Reg by Direct Ext
  • Reg Ipsilateral LN only
  • Reg by Direct & Ipsilateral Reg LN
  • Reg, Nos
  • Distant Site/Node Involv

AJCC TNM 6th Edition

  • cT,pT: Extent of primary tumor
  • cN,pN: Absence or presence & Ext of regional lymph nodes
  • cM,pM: Absence/presence of metastasis

[Clinical (c) and pathologic (p)]

Collaborative Stage

  • CS Tumor Size
  • CS Tumor Size/Ext Eval
  • CS Lymph Nodes
  • CS Lymph Nodes Eval
  • CS Mets at Dx
  • CS Mets Eval
  • CS Site Specific Factors 1-6
collaborative stage
Collaborative Stage
  • General Guidelines
      • Timing Rule
      • Site-specific guidelines
      • Highest applicable number for each field
      • Greatest extent of disease
collaborative stage for bronchus and lung
Collaborative Stage for Bronchus and Lung
  • General Guidelines continued:
      • CS Tumor Size/Ext
      • CS Tumor Size/Ext Eval
      • CS Regional LN
      • CS Reg Nodes Eval
      • CS Mets
      • CS Mets Eval
      • Regional LN Pos/Regional LN Exam
      • Site Specific Factors
collaborative stage for bronchus and lung20
Collaborative Stage for Bronchus and Lung
  • CS Tumor Size

000 No mass/tumor found

001-998 001-998 millimeters (exact size)

989 989 millimeters or larger

990 Microscopic focus or foci only, no size of focus given

991 Described as less than 1 cm

992-995 Described as less than (2,3,4,5 cm)

996 Malignant cells in bronchopulmonary secretions, but no tumor is seen radiographically or during bronchoscopy

997 Diffuse (entire lobe)

998 Diffuse (entire lung)

999 Unknown; size not stated Not documented in patient record

collaborative stage for bronchus and lung21
Collaborative Stage for Bronchus and Lung
  • CS Extension
      • Primary Tumor extension
        • DO NOT CODE DISCONTINOUS METASTASES IN THIS FIELD
      • Priority order for extension
      • Notes 1-7: Read carefully
collaborative stage for bronchus and lung22
Collaborative Stage for Bronchus and Lung
  • CS TS/EXT EVAL
      • Evaluates source for “CS Tumor Size” and

“CS Extension”

      • Describes clinical or pathological staging

of the tumor

collaborative stage for bronchus and lung23
Collaborative Stage for Bronchus and Lung
  • CS TS/EXT EVAL
      • Code 0, 1, 9 No surgery
      • Code 2 Autopsy (diagnosis suspected)
      • Code 3 Surgery followed by other therapy
      • Code 5 Determined prior to neoadjuvant therapy
      • Code 6 Determined after neoadjuvant therapy
      • Code 8 Autopsy (diagnosis unsuspected)
      • Code 9 Unknown, Not assessed, Not stated
collaborative stage for bronchus and lung24
Collaborative Stage for Bronchus and Lung
  • CS Lymph Nodes
      • Regional Nodes and Nodes, NOS only
      • Highest Applicable Code
        • Exception (NOS)
      • New Rule for Inaccessible Site
        • Lung
      • Notes 1-4: Read carefully
collaborative stage for bronchus and lung25
Collaborative Stage for Bronchus and Lung
  • CS Reg Nodes Eval
      • Code 0, 1, 9 No LN(s) removal
      • Code 2 Autopsy (diagnosis suspected)
      • Code 3 LN(s) surgery followed by other therapy
      • Code 5 LN(s) status determined prior to neoadjuvant therapy
      • Code 6 LN(s) status determined after neoadjuvant therapy
      • Code 8 Autopsy (diagnosis unsuspected)
      • Code 9 Unknown, Not assessed, Not stated
collaborative stage for bronchus and lung26
Regional Nodes Positive

00 All nodes examined negative

01-89 1-89 nodes positive

90 or more nodes positive

95 Positive aspiration of LN(s) was performed

97 Positive nodes documented, number unspecified

98 No nodes examined

99 Unknown if nodes positive, not applicable, not stated in record

Regional Nodes Examined

00 No nodes examined

01-89 1-89 nodes examined

90 or more nodes examined

No Reg LN removed, Aspiration of Reg LN performed

Reg LN removal documented as sampling, number unknown/not stated

97 Reg LN removal documented as dissection, number unknown/not stated

98 Reg LN surgically removed, number of LNs unknown/not stated, not documented as sampling or dissection; nodes examined, number unknown

99 Unknown, not applicable, not stated in record

Collaborative Stage for Bronchus and Lung
collaborative stage for bronchus and lung27
Collaborative Stage for Bronchus and Lung
  • CS Mets at Dx
      • 00 No; none
      • 10 Distant Lymph Nodes (s), including cervical nodes
      • 35 Separate tumor nodules (s) in different lobe, same lung
      • 37 Extension to sternum, skeletal muscle, skin of chest
      • 39 Extension to contralateral lung, contralateral main stem bronchus, separate tumor nodule(s) in contralateral lung
      • 40 Abdominal organs, distant metastasis except to distant lymph nodes (code 10), distant mets, NOS, carcinomatosis
      • 50 Distant mets + distant node(s)

(10) + any [35-40]

      • 99 Unknown; distant metastasis cannot be assessed, not documented in patient record.
collaborative stage for bronchus and lung28
Collaborative Stage for Bronchus and Lung
  • CS Mets Eval
    • Code 0, 1, 9 No surgery
    • Code 2 Autopsy (diagnosis suspected)
    • Code 3 Surgery followed by other therapy
    • Code 5 Determined prior to neoadjuvant therapy
    • Code 6 Determined after neoadjuvant therapy
    • Code 8 Autopsy (diagnosis unsuspected)
    • Code 9 Unknown, Not assessed, Not stated
collaborative stage for bronchus and lung29
Collaborative Stage for Bronchus and Lung
  • CS Site Specific Factors
      • SSF 1 Code 888
      • SSF 2 Code 888
      • SSF 3 Code 888
      • SSF 4 Code 888
      • SSF 5 Code 888
      • SSF 6 Code 888
treatment for bronchus and lung
Treatment for Bronchus and Lung
  • Surgery
    • Non-small cell carcinoma: Stage I and II (Localized)
    • Small cell carcinoma: Not recommended
  • Radiation
    • Non-small cell carcinoma: Inoperable, Advanced
    • Small cell carcinoma: Recommended
  • Systemic Therapy
    • Non-small cell carcinoma: Chemotherapy
    • Small cell carcinoma: Combination chemotherapy
  • Hormonal & Endocrine
    • Not proven to be useful
treatment for bronchus and lung31
Treatment for Bronchus and Lung
  • Surgery Codes
        • Primary Site
        • Scope of Regional Lymph Node
        • Surgical Procedure of Other Site
treatment for bronchus and lung32
Treatment for Bronchus and Lung
  • Surgery Codes continued
        • Primary Site
        • Scope of Regional Lymph Node
        • Surgical Procedure of Other Site
treatment for bronchus and lung33
Treatment for Bronchus and Lung
  • Surgery Codes continued
        • Primary Site
        • Scope of Regional Lymph Node
        • Surgical Procedure of Other Site
treatment for bronchus and lung34
Treatment for Bronchus and Lung
  • Radiation
      • Treatment Volume
      • Treatment Modality
      • Regional Dose
      • Boost Modality
      • Boost Dose
      • Prophylactic Cranial Radiation (PCI)
treatment for bronchus and lung35
Treatment for Bronchus and Lung
  • Chemotherapy
    • Non-Small Cell Carcinoma
    • Small Cell Carcinoma
  • Hormones
  • Immunotherapy
  • Other
    • Endoscopic Photodynamic Therapy
keys to abstracting
Keys to Abstracting
  • Organization
      • Dates
      • Procedure Documentation
  • Resources
      • Diagnosis year
  • Text
      • Pertinent
      • Acronyms
ad